[1]
2026. Impact of CYP3A4 and CYP3A5 Genetic Variants on Tacrolimus Dosing and Therapeutic Outcomes in Kidney Transplant Recipients. Majalah Kedokteran Bandung. 58, 2 (Jun. 2026), 123–131. DOI:https://doi.org/10.15395/mkb.v58.4879.